Posted on January 17th, 2012 by
A collaboration of researchers from Wayne State University, the Mayo Clinic, and Johns Hopkins Medicine has discovered a potential new treatment for macular degeneration and retinitis pigmentosa. The investigators managed to attach steroids to dendrimers nanoparticles and show that the drugs only targeted the activated microglia, the damage-causing cells associated with neuroinflammation… Here's a video of lead author Raymond Iezzi about the new delivery system. Additional Coverage: Becker’s ASC Review
The Atlantic, 12/2011
You must be logged-in to the site to post a comment.